MPG.eBooks - Search Results - "Sodium-glucose Transporter 2 Inhibitors"

1

Pharmacoeconomic review report: Empagliflozin (Jardiance)

Published 2015

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

2

Pharmacoeconomic review report: Empagliflozin (Jardiance)

Published 2015

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

3

CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

4

CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

5

Clinical review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

6

Clinical review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

7

Pharmacoeconomic review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

8

Pharmacoeconomic review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

9

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

10

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

11

Sodium-glucose cotransporter 2 inhibitors for the treatment of diabetic nephropathy : a review of clinical effectiveness

by Banerjee, Srabani, Grobelna, Aleksandra
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

12

Pharmacoeconomic review report: Empagliflozin and Metformin fixed-dose combination (Synjardy)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors...”

Read Now

13

Clinical review report: Dapagliflozin (Forxiga)

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors...”

Read Now

14

Common drug review new combination product: Ertugliflozin/Metformin fixed-dose combination (Segluromet) Merck Canada Inc. : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

15

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

16

Common drug review new combination product: Ertugliflozin/Metformin fixed-dose combination (Segluromet) Merck Canada Inc. : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

17

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

18

Empagliflozin (Jardiance)

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

19

Empagliflozin (Jardiance)

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Read Now

20

Sodium-glucose co-transporter 2 inhibitors for the treatment of type 2 diabetes : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Amanda, Shane, Butcher, Robyn
Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Narrow Search